Blue Trust Inc’s X4 Pharmaceuticals XFOR Stock Holding History

Blue Trust Inc’s Portfolio XFOR Stock Details XFOR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.33K	Hold	284	–	–	﹤0.01%	2252
2026 Q1	$1.17K	Hold	284	–	–	﹤0.01%	2233
2025 Q4	$1.14K	Hold	284	–	–	﹤0.01%	2263
2025 Q3	$971	Hold	284	–	–	﹤0.01%	2328
2025 Q2	$540	Hold	284	–	–	﹤0.01%	2311
2025 Q1	$2.01K	Hold	284	–	–	﹤0.01%	2222
2024 Q4	$6.25K	Hold	284	–	–	﹤0.01%	2050
2024 Q3	$4.94K	Hold	284	–	–	﹤0.01%	2404
2024 Q2	$11.8K	Hold	284	–	–	﹤0.01%	1868
2024 Q1	$11.8K	Hold	284	–	–	﹤0.01%	1398
2023 Q4	$9K	Hold	284	–	–	﹤0.01%	1636
2023 Q3	$17K	Hold	284	–	–	﹤0.01%	1235
2023 Q2	$7K	Hold	284	–	–	﹤0.01%	1442
2023 Q1	$8K	Hold	284	–	–	﹤0.01%	1673
2022 Q4	$15K	Hold	284	–	–	﹤0.01%	1410
2022 Q3	$8K	Hold	284	–	–	﹤0.01%	1447
2022 Q2	$15K	Buy	+284	New	+$10.8K	﹤0.01%	1078

Other funds holding XFOR

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BCLSI

Bain Capital Life Sciences Investors Boston, Massachusetts $1.68B AUM 126.09% 1-Year Est. Return

Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return

SVCM

Saturn V Capital Management Austin, Texas $697M AUM 628.57% 1-Year Est. Return

EAM

Empery Asset Management New York $86.5M AUM

DTC

Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

KCM

Kalehua Capital Management Dallas, Texas $174M AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Blue Trust Inc's XFOR Position: Q2 2026 in Review

Blue Trust Inc held its X4 Pharmaceuticals (XFOR) position steady in Q2 2026 at 284 shares worth $1.33K. The position accounts for ﹤0.01% of the portfolio, ranked #2252.

Blue Trust Inc first reported a position in XFOR in Q2 2022 and has held it in 17 quarters since. The position peaked at $17K in Q3 2023. 89 funds tracked by Wall St. Rank hold XFOR as of Q2 2026.

Blue Trust Inc held 284 shares of X4 Pharmaceuticals worth $1.33K as of Q2 2026.
Blue Trust Inc left its X4 Pharmaceuticals share count unchanged in Q2 2026.
X4 Pharmaceuticals made up ﹤0.01% of Blue Trust Inc's portfolio in Q2 2026, its #2252 holding.
Blue Trust Inc first reported a position in X4 Pharmaceuticals in Q2 2022 and has held it in 17 quarters since.
Blue Trust Inc's X4 Pharmaceuticals position peaked at $17K in Q3 2023.
89 funds tracked by Wall St. Rank held X4 Pharmaceuticals as of Q2 2026.

Based on Blue Trust Inc's 13F filing for Q2 2026, filed 21 Jul 2026.